{"title":"[胰腺癌的全身治疗]。","authors":"Gábor Lakatos","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Pancreatic cancer is a devastating disease, survival rates did not improve during the last decades. At the same time new drugs and chemotherapy regimens have been approved for systemic use lately, the results of targeted therapy and the precision medicine approach are also encouraging. Further progress is needed covering all treatment modalities (surgery, radiotherapy, systemic treatment) in order to improve outcome of patients suffering from pancreatic cancer.</p>","PeriodicalId":18175,"journal":{"name":"Magyar onkologia","volume":"65 3","pages":"273-281"},"PeriodicalIF":0.0000,"publicationDate":"2021-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Systemic treatment of pancreatic cancer].\",\"authors\":\"Gábor Lakatos\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Pancreatic cancer is a devastating disease, survival rates did not improve during the last decades. At the same time new drugs and chemotherapy regimens have been approved for systemic use lately, the results of targeted therapy and the precision medicine approach are also encouraging. Further progress is needed covering all treatment modalities (surgery, radiotherapy, systemic treatment) in order to improve outcome of patients suffering from pancreatic cancer.</p>\",\"PeriodicalId\":18175,\"journal\":{\"name\":\"Magyar onkologia\",\"volume\":\"65 3\",\"pages\":\"273-281\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-10-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Magyar onkologia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2021/7/20 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Magyar onkologia","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/7/20 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
Pancreatic cancer is a devastating disease, survival rates did not improve during the last decades. At the same time new drugs and chemotherapy regimens have been approved for systemic use lately, the results of targeted therapy and the precision medicine approach are also encouraging. Further progress is needed covering all treatment modalities (surgery, radiotherapy, systemic treatment) in order to improve outcome of patients suffering from pancreatic cancer.